Plasma apolipoprotein B-48 transport in obese men: A new tracer kinetic study in the postprandial state

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 1, 2014, Pages

  Wong, Annette T Y ^a   Chan, Dick C ^a   Pang, Jing ^a   Watts, Gerald F ^a   Barrett, P Hugh R ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B48; LEUCINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY FAT; CATABOLISM; CLINICAL ARTICLE; COMPARTMENT MODEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HYPERTRIGLYCERIDEMIA; LEAN BODY WEIGHT; MALE; MASS FRAGMENTOGRAPHY; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN TRANSPORT; STEADY STATE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; APOLIPOPROTEIN B-48; BLOOD PROTEINS; HUMANS; ISOTOPE LABELING; KINETICS; LEUCINE; MALE; MIDDLE AGED; OBESITY; POSTPRANDIAL PERIOD; PROTEIN TRANSPORT; RADIOACTIVE TRACERS; THINNESS;

EID: 84892144056     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2477     Document Type: Article

References (19)

1. Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease. Circulation. 2011;123:2292-2333.
2. Alipour A, Valdivielso P, Elte JWF, et al. Exploring the value of apoB 48 as a marker for atherosclerosis in clinical practice. Eur J Clin Invest. 2012;42:702-708.
3. Proctor SD, Vine DF, Mamo JCL. Arterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherogenesis. Curr Opin Lipidol. 2002;13:461-470.
4. Tomkin GH, Owens D. Abnormalis in apo B-containing lipoproteins in diabetes and atherosclerosis. Diabetes Metab Res Rev. 2001; 17:27-43.
5. Mamo JCL, Watts GF, Barrett PHR, Smith D, James AP, Pal S. Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression? Am J Physiol Endocrinol Metab. 2001;281:E626-E632.
6. Dwyer KP, Barrett PHR, Chan D, Foo JI, Watts GF, Croft KD. Oxazolinone derivative of leucine for GC-MS: a sensitive and robust method for stable isotope kinetic studies of lipoproteins. J Lipid Res. 2002;43:344-349.
7. Le NA, Coates PM, Gallagher, Cortner JA. Kinetics of retinyl esters during postprandial lipemia in man: a compartmental model. Metabolism. 1997;46:584-594.
8. Chan DC, Watts GF, Gan S, Wong ATY, Ooi EMM, Barrett PHR. Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein apolipoprotein B-100 in Obesity. Arterioscler Thromb Vasc Biol. 2010;30:1043-1050.
9. Couillard C, Bergeron N, Pascot A, et al. Evidence for impaired lipolysis in abdominally obese men: postprandial study of apolipoprotein B-48- and B-100-containing lipoproteins. Am J Clin Nutr. 2002;76:311-318.
10. Blackburn P, Lamarche B, Couillard C, et al. Postprandial hyperlipidemia: another correlate of the "hypertriglyceridemic waist" phenotype in men. Atherosclerosis. 2003;171:327-336.
11. Hogue J-C, Lamarche B, Tremblay AJ, Bergeron J, Gagné C, Couture P. Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes. J Lipid Res. 2007;48:1336-1342.
12. Chan DC, Watts GF, Barrett PH, Mamo JCL, Redgrave TG. Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity. Clin Chem. 2002;48:278-283.
13. Adeli K, Lewis GF. Intestinal lipoprotein overproduction in insulinresistant states. Curr Opin Lipidol. 2008;19:221-228.
14. Duez H, Lamarche B, Uffelman KD, Valero R, Cohn JS, Lewis GF. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans. Arterioscler Thromb Vasc Biol. 2006;26:1357-1363.
15. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endo Rev. 2000;21:697-738.
16. Chan DC, Watts GF, Redgrave TG, Mori TA, Barrett PHR. Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration. Metabolism. 2002;51:1041-1046.
17. Panarotto D, Remillard P, Bouffard L, Maheux P. Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner. Eur J Clin Invest. 2002; 32:84-92.
18. Mazzone T, Foster D, Chait A. In vivo stimulation of low-density lipoprotein degradation by insulin. Diabetes. 1984;33:333-338.
19. Chan DC, Watts GF, Nguyen MN, Barrett PH. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics. Arterioscler Thromb Vasc Biol. 2006;26:590-626.